Other News

Endologix Appoints Jeffrey S. Brown as Chief Operations Officer

IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that it has appointed Jeffrey S. Brown as the Company’s Chief Operations Officer, effective as of August 13, 2018. John Onopchenko, Chief Executive Officer of Endologix, Inc., said, “I […]

BioAxone BioSciences’ Scientific Advisory Board Member, Mark Bear, PhD, Receives $500,000 Beckman-Argyros Vision Research Award

CAMBRIDGE, Mass.–(BUSINESS WIRE)–BioAxone BioSciences, Inc., a biotechnology company focused on developing innovative drugs to treat neurotrauma and neurovascular disorders, today announced that its Scientific Advisory Board member, Dr. Mark Bear, the Picower Professor of Neuroscience at the Massachusetts Institute of Technology, received the prestigious Arnold and Mabel Beckman Foundation 2018 Beckman-Argyros […]

ROX Medical Appoints Mike MacKinnon as Chief Executive Officer

SAN CLEMENTE, Calif., Aug. 14, 2018 /PRNewswire/ — ROX Medical, Inc. (ROX), a privately held medical device company pioneering a minimally-invasive therapy for hypertension, today announced the appointment of Mike MacKinnon as its Chief Executive Officer. “Despite the many classes of drugs available to physicians to treat hypertension, millions of patients still have blood pressures […]

AngioDynamics Provides Updates on Oncology and Vascular Access Businesses

LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today provided a corporate update on enhancements made to its Oncology business and acknowledged a recent, favorable U.S. District Court ruling that impacts its Vascular Access business. […]

BioSig Technologies Announces FDA 510(k) Clearance for PURE EP System

Santa Monica, CA, Aug. 14, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), announced that the Company has received 510(k) clearance for its first product, PURE EP System, from the U.S. Food and Drug Administration (FDA). The non-invasive PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring […]

Catasys to Announce Second Quarter 2018 Results and Host Conference Call on August 14, 2018

LOS ANGELES–(BUSINESS WIRE)–Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its second quarter and six months ended June 30, 2018, after the closing of the stock market on Tuesday, August 14, 2018. The Company […]

Itamar Medical Reports Second Quarter 2018 Financial Results

CAESAREA, Israel, Aug. 13, 2018 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (TASE: ITMR), a company that develops, manufactures, and markets non-invasive diagnostic medical devices for sleep-apnea with a focus on the cardiology market, today reported financial results for the second quarter of 2018. “Itamar Medical continues to demonstrate double-digit growth […]

BioSig Technologies Completes Private Placement

Santa Monica, CA, Aug. 13, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company closed a private placement of $4,281,000. Combined with the […]

Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection

WINNIPEG, Aug. 13, 2018 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce that the United States Food and Drug Administration (“FDA”) has approved its Abbreviated New Drug Application (“ANDA”) for Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL) single dose vial (“SNP”), […]